You have 9 free searches left this month | for more free features.

City

Baltimore (1)

Glasgow (1)

Houston (1)

Leeds (1)

London (1)

Manchester (1)

Newcastel Upon Tyne (1)

Sutton (1)

Condition

Advanced or Refractory Leukemia (1)

Lymphoma (1)

Myelodysplastic Syndromes (1)

Neoplasms (1)

Overall Status

Completed (1)

Terminated (1)

Phase

phase 1 (2)

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)

Collaborator

Janssen Pharmaceutica N.V., Belgium (1)

Intervention

jnj-26481585 (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

jnj-26481585

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced or Refractory Leukemia, MDS Trial in Baltimore, Houston (JNJ-26481585)

Terminated

Advanced or Refractory Leukemia
Myelodysplastic Syndromes

JNJ-26481585

Baltimore, Maryland
+1 more

Sep 13, 2012

Lymphoma, Tumors Trial in United Kingdom (JNJ-26481585)

Completed

Lymphoma
Neoplasms

JNJ-26481585

Glasgow, United Kingdom
+5 more

Sep 14, 2012